|
Basiliximab
|
D12.776.124.790.651.114.224.060.407 |
|
|
Gastric Absorption
|
G03.015.500.374.249 |
|
|
Administration, Intranasal
|
E02.319.267.120.655.500 |
|
|
Rhinoscleroma
|
C17.800.838.765.705 |
|
|
Biomineralization
|
G11.427.578.050 |
|
|
Kininogen, High-Molecular-Weight
|
D12.776.811.420.350 |
|
|
Protamine Kinase
|
D08.811.913.696.620.682.700.150.575 |
|
|
Cyclic Nucleotide-Regulated Protein Kinases
|
D08.811.913.696.620.682.700.150 |
|
|
Heart Bypass, Right
|
E04.100.376.410 |
|
|
Credentialing
|
N05.700.200 |
|
|
Controlled Clinical Trials as Topic
|
N05.715.360.330.250.250.365 |
|
|
Neoplasms, Glandular and Epithelial
|
C04.557.470 |
|
|
Glucosinolates
|
D02.886.740.703.350 |
|
|
Thioglucosides
|
D02.886.740.703 |
|
|
Medical Staff, Hospital
|
M01.526.485.740.422 |
|
|
Bacterial Proton-Translocating ATPases
|
D08.811.913.696.650.150.500.249 |
|
|
Amoxicillin-Potassium Clavulanate Combination
|
D02.065.589.099.750.750.050.050.060 |
|
|
Nasal Surgical Procedures
|
E04.580.392 |
|
|
Inosine Pranobex
|
D13.570.800.573.450 |
|
|
Motion Therapy, Continuous Passive
|
E02.760.169.063.500.387.500 |
|
